Intranasal CRMP2-Ubc9 inhibitor regulates Na V 1.7 to alleviate trigeminal neuropathic pain.
Loya-Lopez SI, Allen HN, Duran P, Calderon-Rivera A, Gomez K, Kumar U, Shields R, Zeng R, Dwivedi A, Saurabh S, Korczeniewska OA, Khanna R.
Loya-Lopez SI, et al. Among authors: gomez k.
Pain. 2024 Mar 1;165(3):573-588. doi: 10.1097/j.pain.0000000000003053. Epub 2023 Sep 26.
Pain. 2024.
PMID: 37751532